Expanding the toolbox for predictive parameters describing antibody stability considering thermodynamic and kinetic determinants.
activiation energy
antibody stability
intrinsic fluorescence and differential scanning calorimetry
kinetic stability
predictive parameter
thermal unfolding
thermodynamic stability
van’t Hoff enthalpy
Journal
Pharmaceutical research
ISSN: 1573-904X
Titre abrégé: Pharm Res
Pays: United States
ID NLM: 8406521
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
15
11
2020
accepted:
03
10
2021
pubmed:
15
12
2021
medline:
1
3
2022
entrez:
14
12
2021
Statut:
ppublish
Résumé
Introduction of the activation energy (E E E E
Identifiants
pubmed: 34904201
doi: 10.1007/s11095-021-03120-x
pii: 10.1007/s11095-021-03120-x
doi:
Substances chimiques
Antibodies, Monoclonal
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2065-2089Subventions
Organisme : German Federal Ministry of Education and Research, funding program KMU-innovativ Photonics Research Germany
ID : 13N14245
Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Kesik-Brodacka M. Progress in biopharmaceutical development. Biotechnol Appl Bioc. 2018;65:306–22.
Amin S, Barnett GV, Pathak JA, Roberts CJ, Sarangapani PS. Protein aggregation, particle formation, characterization & rheology. Curr Opin Colloid In. 2014;19:438–49.
Keizer RJ, Huitema ADR, Schellens JHM, Beijnen JH. Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies. Clin Pharmacokinet. 2010;49:493–507.
pubmed: 20608753
den Engelsman J, Garidel P, Smulders R, Koll H, Smith B, Bassarab S, et al. Strategies for the Assessment of Protein Aggregates in Pharmaceutical Biotech Product Development. Pharmaceutical Res. 2011;28:920–33.
Lowe D, Dudgeon K, Rouet R, Schofield P, Jermutus L, Christ D. Aggregation, stability, and formulation of human antibody therapeutics. Adv Protein Chem Str. 2011;84:41–61.
Roberts CJ. Non-native protein aggregation kinetics. Biotechnol Bioeng. 2007;98:927–38.
pubmed: 17705294
Vlasak J, Ionescu R. Fragmentation of monoclonal antibodies. Mabs. 2011;3:253–63.
pubmed: 21487244
pmcid: 3149706
Wang W. Protein aggregation and its inhibition in biopharmaceutics. Int J Pharmaceut. 2005;289:1–30.
Wang W, Nema S, Teagarden D. Protein aggregation—Pathways and influencing factors. Int J Pharmaceut. 2010;390:89–99.
Zbacnik NJ, Henry CS, Manning MC. A Chemometric Approach Toward Predicting the Relative Aggregation Propensity: Aβ(1-42). J Pharm Sci. 2020;109:624–32.
pubmed: 31606543
Frokjaer S, Otzen DE. Protein drug stability: a formulation challenge. Nat Rev Drug Discov. 2005;4:298–306.
pubmed: 15803194
Lumry R, Eyring H. Conformation Changes of Proteins. J Phys Chem. 1954;58:110–20.
Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int J Pharmaceut. 1999;185:129–88.
Brader ML, Estey T, Bai S, Alston RW, Lucas KK, Lantz S, et al. Examination of Thermal Unfolding and Aggregation Profiles of a Series of Developable Therapeutic Monoclonal Antibodies. Mol Pharmaceut. 2015;12:1005–17.
Garidel P, Eiperle A, Blech M, Seelig J. Thermal and Chemical Unfolding of a Monoclonal IgG1 Antibody: Application of the Multistate Zimm-Bragg Theory. Biophys J. 2020;118:1067–75.
pubmed: 32049058
pmcid: 7063443
Seelig J. Cooperative protein unfolding. A statistical-mechanical model for the action of denaturants. Biophys Chem. 2018;233:19–25.
pubmed: 29232602
Seelig J, Schönfeld H-J. Thermal protein unfolding by differential scanning calorimetry and circular dichroism spectroscopy Two-state model versus sequential unfolding. Q Rev Biophys. 2016;49:e9.
pubmed: 27658613
Zimm BH, Bragg JK. Theory of the Phase Transition between Helix and Random Coil in Polypeptide Chains. J Chem Phys. 1959;31:526–35.
Mazurenko S, Kunka A, Beerens K, Johnson CM, Damborsky J, Prokop Z. Exploration of Protein Unfolding by Modelling Calorimetry Data from Reheating. Sci Rep-uk. 2017;7:16321.
Bedouelle H. Principles and equations for measuring and interpreting protein stability: From monomer to tetramer. Biochimie. 2016;121:29–37.
pubmed: 26607240
Colón W, Church J, Sen J, Thibeault J, Trasatti H, Xia K. Biological Roles of Protein Kinetic Stability. Biochemistry-us. 2017;56:6179–86.
Finkelstein AV, Badretdin AJ, Galzitskaya OV, Ivankov DN, Bogatyreva NS, Garbuzynskiy SO. There and back again: Two views on the protein folding puzzle. Phys Life Rev. 2017;21:56–71.
pubmed: 28190683
Nemergut M, Žoldák G, Schaefer JV, Kast F, Miškovský P, Plückthun A, et al. Analysis of IgG kinetic stability by differential scanning calorimetry, probe fluorescence and light scattering. Protein Sci. 2017;26:2229–39.
pubmed: 28833802
pmcid: 5654860
Wang W, Singh S, Zeng DL, King K, Nema S. Antibody structure, instability, and formulation. J Pharm Sci. 2007;96:1–26.
pubmed: 16998873
Bruylants G, Wouters J, Michaux C. Differential scanning calorimetry in life science: thermodynamics, stability, molecular recognition and application in drug design. Curr Med Chem. 2005;12:2011–20.
pubmed: 16101501
Gill P, Moghadam TT, Ranjbar B. Differential scanning calorimetry techniques: applications in biology and nanoscience. J Biomol Tech [Internet]. 2010;21:167–93 Available from: http://www.ncbi.nlm.nih.gov/pubmed/21119929.
pmcid: 2977967
Clarkson BR, Schön A, Freire E. Conformational stability and self-association equilibrium in biologics. Drug Discov Today. 2016;21:342–7.
pubmed: 26608889
Garidel P, Hegyi M, Bassarab S, Weichel M. A rapid, sensitive and economical assessment of monoclonal antibody conformational stability by intrinsic tryptophan fluorescence spectroscopy. Biotechnol J. 2008;3:1201–11.
pubmed: 18702089
Blaffert J, Haeri HH, Blech M, Hinderberger D, Garidel P. Spectroscopic methods for assessing the molecular origins of macroscopic solution properties of highly concentrated liquid protein solutions. Analytical Biochem. 2018;561–562:70–88.
Dennis B, P L, A. S, F. S, Patrick G, Blech M. Getting the Full Picture: Predicting the Aggregation propensity of mAbs Using Chemical and Thermal Denaturation on a Single, Fully Automated Platform. Application Note NT-PR-011. 2016;1–7.
Eftink MR. The use of fluorescence methods to monitor unfolding transitions in proteins. Biophys J. 1994;66:482–501.
pubmed: 8161701
pmcid: 1275715
Melien R, Garidel P, Hinderberger D, Blech M. Thermodynamic Unfolding and Aggregation Fingerprints of Monoclonal Antibodies Using Thermal Profiling. Pharmaceutical Research [Internet]. 2020;37:78. Available from: https://doi.org/10.1007/s11095-020-02792-1
Bianco V, Franzese G, Coluzza I. In Silico Evidence That Protein Unfolding is a Precursor of Protein Aggregation. Chemphyschem. 2020;21:377–84.
pubmed: 31721405
Chennamsetty N, Voynov V, Kayser V, Helk B, Trout BL. Prediction of Aggregation Prone Regions of Therapeutic Proteins. J Phys Chem B. 2010;114:6614–24.
pubmed: 20411962
Ebo JS, Guthertz N, Radford SE, Brockwell DJ. Using protein engineering to understand and modulate aggregation. Curr Opin Struc Biol. 2020;60:157–66.
Kerwin BA, Bennett C, Brodsky Y, Clark R, Floyd JA, Gillespie A, et al. Framework Mutations of the 10-1074 bnAb Increase Conformational Stability, Manufacturability, and Stability While Preserving Full Neutralization Activity. J Pharm Sci. 2020;109:233–46.
pubmed: 31348937
pmcid: 6941225
Lauer TM, Agrawal NJ, Chennamsetty N, Egodage K, Helk B, Trout BL. Developability index: A rapid in silico tool for the screening of antibody aggregation propensity. J Pharm Sci. 2012;101:102–15.
pubmed: 21935950
Prabakaran R, Rawat P, Thangakani AM, Kumar S, Gromiha MM. Protein aggregation: in silico algorithms and applications. Biophysical Rev. 2021;13:71–89.
Seeliger D, Schulz P, Litzenburger T, Spitz J, Hoerer S. Blech M, et al. Boosting antibody developability through rational sequence optimization. mAbs. 2015;7:505–15.
pubmed: 25759214
Pérez A-MW, Sormanni P, Andersen JS, Sakhnini LI, Rodriguez-Leon I, Bjelke JR, et al. In vitro and in silico assessment of the developability of a designed monoclonal antibody library. Mabs. 2018;11:388–400.
van der Kant R, Karow-Zwick AR, Durme JV, Blech M, Gallardo R, Seeliger D, et al. Prediction and Reduction of the Aggregation of Monoclonal Antibodies. J Mole Biol. 2017;429:1244–61.
Willis LF, Kumar A, Jain T, Caffry I, Xu Y, Radford SE, et al. The uniqueness of flow in probing the aggregation behavior of clinically relevant antibodies. Eng Reports. 2020;2.
Kumar S, Singh SK. Developability of Biotherapeutics: Computational Approaches [Internet]. CRC Press; 2016. Available from: https://books.google.de/books?id=FI_wCgAAQBAJ
Wang X, Das TK, Singh SK, Kumar S. Potential aggregation prone regions in biotherapeutics: A survey of commercial monoclonal antibodies. Mabs. 2009;1:254–67.
pubmed: 20065649
pmcid: 2726584
Bergemann K, Eckermann C, Garidel P, Grammatikos S, Jacobi A, Kaufmann H, et al. Production and downstream processing. Handbook Therap Antibodies. 2007:199–237.
Wang S, Raghani A. Arginine as an eluent for automated on-line Protein A/size exclusion chromatographic analysis of monoclonal antibody aggregates in cell culture. J Chromatogr B. 2014;945:115–20.
Yumioka R, Sato H, Tomizawa H, Yamasaki Y, Ejima D. Mobile phase containing arginine provides more reliable SEC condition for aggregation analysis. J Pharm Sci. 2010;99:618–20.
pubmed: 19569199
Garidel P. Steady-state intrinsic tryptophan protein fluorescence spectroscopy in pharmaceutical biotechnology. Spectroscopy Eur. 2008;4:7–11.
Garidel P, Karow AR, Blech M. Orthogonal spectroscopic techniques for the early developability assessment of therapeutic protein candidates. Spectroscopic Eur. 2014;4:9–13.
Cai J, Yao F, Yi W, He F. New temperature integral approximation for nonisothermal kinetics. Aiche J. 2006;52:1554–7.
Cai J, Liu R. An improved version of Junmeng–Fang–Weiming–Fusheng approximation for the temperature integral. J Math Chem. 2008;43:1193–8.
Boehm K, Guddorf J, Albers A, Kamiyama T, Fetzner S, Hinz H-J. Thermodynamic Analysis of Denaturant-Induced Unfolding of HodC69S Protein Supports a Three-State Mechanism. Biochemistry-us. 2008;47:7116–26.
Temel DB, Landsman P, Brader ML. Chapter Fourteen Orthogonal Methods for Characterizing the Unfolding of Therapeutic Monoclonal Antibodies Differential Scanning Calorimetry, Isothermal Chemical Denaturation, and Intrinsic Fluorescence with Concomitant Static Light Scattering. Methods Enzymol. 2016;567:359–89.
pubmed: 26794361
Garber E, Demarest SJ. A broad range of Fab stabilities within a host of therapeutic IgGs. Biochem Bioph Res Co. 2007;355:751–7.
Ionescu RM, Vlasak J, Price C, Kirchmeier M. Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodies. J Pharm Sci. 2008;97:1414–26.
pubmed: 17721938
Thakkar SV, Joshi SB, Jones ME, Sathish HA, Bishop SM, Volkin DB, et al. Excipients differentially influence the conformational stability and pretransition dynamics of two IgG1 monoclonal antibodies. J Pharm Sci. 2012;101:3062–77.
pubmed: 22581714
Igawa T, Tsunoda H, Kuramochi T, Sampei Z, Ishii S, Hattori K. Engineering the variable region of therapeutic IgG antibodies. Mabs. 2011;3:243–52.
pubmed: 21406966
pmcid: 3149705
Goldberg DS, Bishop SM, Shah AU, Sathish HA. Formulation development of therapeutic monoclonal antibodies using high-throughput fluorescence and static light scattering techniques: Role of conformational and colloidal stability. J Pharm Sci. 2011;100:1306–15.
pubmed: 20960568
Harn N, Allan C, Oliver C, Middaugh CR. Highly concentrated monoclonal antibody solutions: Direct analysis of physical structure and thermal stability. J Pharm Sci. 2007;96:532–46.
pubmed: 17083094
Maity H, O’Dell C, Srivastava A, Goldstein J. Effects of Arginine on Photostability and Thermal Stability of IgG1 Monoclonal Antibodies. Curr Pharm Biotechno. 2009;10:761–6.
Andrews JM, Roberts CJ. A Lumry−Eyring Nucleated Polymerization Model of Protein Aggregation Kinetics: 1. Aggregation with Pre-Equilibrated Unfolding. J Phys Chem B. 2007;111:7897–913.
pubmed: 17571872
Privalov PL, Potekhin SA. Scanning microcalorimetry in studying temperature-induced changes in proteins. Methods Enzymol. 1986;131:4–51.
pubmed: 3773768
Færgeman NJ, Sigurskjold BW, Kragelund BB, Andersen KV, Knudsen J. Thermodynamics of Ligand Binding to Acyl-Coenzyme A Binding Protein Studied by Titration Calorimetry †. Biochemistry-us. 1996;35:14118–26.
Voordouw G, Milo C, Roche RS. Role of bound calcium ions in thermostable, proteolytic enzymes. Separation of intrinsic and calcium ion contributions to the kinetic thermal stability. Biochemistry. 1976;17:3716–24.
Fujita SC, Go N, Imahori K. Melting-profile analysis of thermal stability of thermolysin. A formulation of temperature-scanning kinetics. Biochemistry-us. 1979;18:24–8.
Andersen CB, Manno M, Rischel C, Thórólfsson M, Martorana V. Aggregation of a multidomain protein: A coagulation mechanism governs aggregation of a model IgG1 antibody under weak thermal stress. Protein Sci. 2010;19:279–90.
pubmed: 20014440
Ahrer K, Buchacher A, Iberer G, Jungbauer A. Thermodynamic stability and formation of aggregates of human immunoglobulin G characterised by differential scanning calorimetry and dynamic light scattering. J Biochem Bioph Meth. 2006;66:73–86.
Saluja A, Sadineni V, Mungikar A, Nashine V, Kroetsch A, Dahlheim C, et al. Significance of Unfolding Thermodynamics for Predicting Aggregation Kinetics: A Case Study on High Concentration Solutions of a Multi-Domain Protein. Pharmaceut Res. 2014;31:1575–87.
Eliseev IE, Yudenko AN, Besedina NA, Ulitin AB, Ekimova VM, Evdokimov SR, et al. Thermodynamic Analysis of the Conformational Stability of a Single-Domain Therapeutic Antibody. Tech Phys Lett. 2017;43:1088–91.
Famm K, Hansen L, Christ D, Winter G. Thermodynamically Stable Aggregation-Resistant Antibody Domains through Directed Evolution. J Mol Biol. 2008;376:926–31.
pubmed: 18199455
Kim N, Remmele RL, Liu D, Razinkov VI, Fernandez EJ, Roberts CJ. Aggregation of anti-streptavidin immunoglobulin gamma-1 involves Fab unfolding and competing growth pathways mediated by pH and salt concentration. Biophys Chem [Internet]. 2013;172:26–36. Available from: http://www.sciencedirect.com/science/article/pii/S0301462212001524
Barnett GV, Razinkov VI, Kerwin BA, Hillsley A, Roberts CJ. Acetate- and Citrate-Specific Ion Effects on Unfolding and Temperature-Dependent Aggregation Rates of Anti-Streptavidin IgG1. J Pharm Sci. 2016;105:1066–73.
pubmed: 26886346
Shire SJ, Shahrokh Z, Liu J. Challenges in the development of high protein concentration formulations. J Pharm Sci. 2004;93:1390–402.
pubmed: 15124199
Kayser V, Chennamsetty N, Voynov V, Helk B, Forrer K, Trout BL. Evaluation of a non-arrhenius model for therapeutic monoclonal antibody aggregation. J Pharm Sci. 2011;100:2526–42.
pubmed: 21268027
Wang W, Roberts CJ. Non-Arrhenius Protein Aggregation. Aaps J. 2013;15:840–51.
pubmed: 23615748
pmcid: 3691426
Chi EY, Krishnan S, Randolph TW, Carpenter JF. Physical Stability of Proteins in Aqueous Solution: Mechanism and Driving Forces in Nonnative Protein Aggregation. Pharmaceut Res. 2003;20:1325–36.
Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. International journal of pharmaceutics [Internet]. 1999;185:129–88. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10460913 . Accessed 2 Oct 2013
Hari SB, Lau H, Razinkov VI, Chen S, Latypov RF. Acid-Induced Aggregation of Human Monoclonal IgG1 and IgG2: Molecular Mechanism and the Effect of Solution Composition. Biochemistry-us. 2010;49:9328–38.
Mehta SB, Bee JS, Randolph TW, Carpenter JF. Partial Unfolding of a Monoclonal Antibody: Role of a Single Domain in Driving Protein Aggregation. Biochemistry-us. 2014;53:3367–77.
Sahin E, Grillo AO, Perkins MD, Roberts CJ. Comparative effects of pH and ionic strength on protein-protein interactions, unfolding, and aggregation for IgG1 antibodies. J Pharm Sci [Internet]. 2010;99:4830–48 Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-78049249356 , https://doi.org/10.1002/jps.22198 . Accessed 6 Jul 2015
Brummitt RK, Nesta DP, Chang L, Chase SF, Laue TM, Roberts CJ. Nonnative aggregation of an IgG1 antibody in acidic conditions: Part 1. Unfolding, colloidal interactions, and formation of high-molecular-weight aggregates. J Pharm Sci [Internet]. 2011;100:2087–103. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-79954531753 , https://doi.org/10.1002/jps.22448 . Accessed 7 Apr 2014
Weiss WF, Young TM, Roberts CJ. Principles, approaches, and challenges for predicting protein aggregation rates and shelf life. J Pharm Sci. 2009;98:1246–77.
pubmed: 18683878
Cromwell MEM, Hilario E, Jacobson F. Protein aggregation and bioprocessing. Aaps J. 2006;8:E572–9.
pubmed: 17025275
pmcid: 2761064
Hu L, Olsen C, Maddux N, Joshi SB, Volkin DB, Middaugh CR. Investigation of Protein Conformational Stability Employing a Multimodal Spectrometer. Anal Chem. 2011;83:9399–405.
pubmed: 22047496
Samra HS, He F. Advancements in High Throughput Biophysical Technologies: Applications for Characterization and Screening during Early Formulation Development of Monoclonal Antibodies. Mol Pharmaceut. 2012;9:696–707.
Cohen SL, Price C, Vlasak J. β-Elimination and Peptide Bond Hydrolysis: Two Distinct Mechanisms of Human IgG1 Hinge Fragmentation upon Storage. J Am Chem Soc. 2007;129:6976–7.
pubmed: 17500521
Gaza-Bulseco G, Liu H. Fragmentation of a Recombinant Monoclonal Antibody at Various pH. Pharmaceut Res. 2008;25:1881–90.